Evidence map›Paper›PMID 42396642›Full record

ArticleMolecular medicine reports2026

Mengjie He, Zixuan Liu, Yuxin Chen, Xiaoru Wu, Xueling Dai, Qian Liu, Shuo Wang, Zeping Zuo, Yaxuan Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengjie He *Beijing Key Laboratory of Bioactive Substances and Functional Food, College of Biochemical Engineering, Beijing Union University, Beijing 100191, P.R. China.
Zixuan Liu *Beijing Key Laboratory of Bioactive Substances and Functional Food, College of Biochemical Engineering, Beijing Union University, Beijing 100191, P.R. China.
Yuxin ChenBeijing Key Laboratory of Bioactive Substances and Functional Food, College of Biochemical Engineering, Beijing Union University, Beijing 100191, P.R. China.
Xiaoru WuBeijing Tongrentang Company Limited, Beijing 100062, P.R. China.
Xueling DaiBeijing Key Laboratory of Bioactive Substances and Functional Food, College of Biochemical Engineering, Beijing Union University, Beijing 100191, P.R. China.
Qian LiuBeijing Key Laboratory of Bioactive Substances and Functional Food, College of Biochemical Engineering, Beijing Union University, Beijing 100191, P.R. China.
Shuo WangTianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300350, P.R. China.
Zeping Zuo *Beijing Tongrentang Company Limited, Beijing 100062, P.R. China.
Yaxuan Sun *Beijing Key Laboratory of Bioactive Substances and Functional Food, College of Biochemical Engineering, Beijing Union University, Beijing 100191, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to elucidate the regulatory effect of

Indexed as

Antidepressive AgentsBrain-Derived Neurotrophic FactorCorticosteroneDepressionGastrointestinal MicrobiomeMorindaOligosaccharidesSignal TransductionAnimalsBehavior, AnimalCyclic AMP Response Element-Binding ProteinDisease Models, AnimalHippocampusMaleMiceReceptor, trkBAntidepressive AgentsBdnf protein, mouseBrain-Derived Neurotrophic FactorCorticosteroneCyclic AMP Response Element-Binding ProteinOligosaccharidesReceptor, trkBbrain‑derived neurotrophic factorcorticosteronedepressiongut microbiotaMorinda officinalis oligosaccharidesneuronal injury

Identifiers

PMID42396642
PMCPMC13343119

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.